U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07422012) titled 'Tacrolimus in Pregnancy' on Feb. 06.
Brief Summary: To create a formula that adjusts tacrolimus blood levels. This is needed because pregnant patients have higher levels of unbound tacrolimus. The adjusted formula will give a more accurate measure of the active drug in pregnant uterus transplant patients.
Study Start Date: March, 2026
Study Type: OBSERVATIONAL
Condition:
Unbound Tacrolimus in Pregnant Uterus Transplant Recipients
Whole Blood Tacrolimus in Pregnant Uterus Transplant Recipients
Intervention:
BIOLOGICAL: Modeling of unbound and whole blood tacrolimus in pregnant uterus transplant recipients
Develop an estimating...